Stock listing

Medincell Sa

Selected listing: MEDCL · BX · CHF · CH

Medincell Sa (BX Swiss: MEDCL), Health Technology. Latest release Sep 30, 2026: Medincell : prolongation exceptionnelle de la période de vote par…

MEDCL:BXCHFCHUpdated September 25, 2026

Ticker: BX Swiss: MEDCL
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

About Medincell Sa

Medincell SA is a public company listed on the French market under the ticker MEDCL. Medincell focuses on developing innovative drug delivery solutions to improve patient outcomes.

Latest news from Medincell Sa

Medincell : prolongation exceptionnelle de la période de vote par correspondance pour l’Assemblée Générale jusqu'à 15h00 aujourd'hui

September 29, 2026

Medincell Extends Remote Voting Deadline for its Annual General Meeting Until 3:00 p.m. Today

September 30, 2026

Medincell to Participate in Upcoming Investor Conferences

September 9, 2026

Medincell: Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting

September 8, 2026

Medincell Appoints Edna Venneker, MD, as Chief Medical Officer

September 1, 2026

All Medincell Sa news →

Events

Replays

Medincell (MDCLF) Q2 2026 Earnings Call
Tue, Dec 09, 2025 · 01:00 PM ET
Watch
Medincell (MDCLF) Q4 2021 Earnings Call
Tue, Jun 14, 2022 · 08:30 PM ET
Watch
Medincell (MDCLF) Q2 2021 Earnings Call
Tue, Dec 07, 2021 · 08:30 PM ET
Watch

Research Medincell Sa

Medincell Sa company profile

View the public company page for Medincell Sa on 6ix.

Medincell Sa news

Read company news and market updates connected to Medincell Sa.

Medincell Sa investor events

Find investor webinars, events, and replay context for Medincell Sa.